endo-BCN-Val-Cit-PAB-MMAE

endo-BCN-Val-Cit-PAB-MMAE

endo-BCN-Val-Cit-PAB-MMAE is a synthetic antibody-drug conjugate (ADC) coupled to a BCN group. It contains a protease-sensitive Val-Cit dipeptide and an MMAE payload. The MMAE is a synthetic antineoplastic agent. The BCN group can react with azide-tagged compounds or biomolecules.

Molecular structure of the compound BP-28192
    • Unit
    • Price
    • Qty
    • 5 MG
    • $540.00
    • 10 MG
    • $870.00
    • 25 MG
    • $1500.00
    • 50 MG
    • $2200.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Lili Liu, Hong Liang, Daniel Victor Perlroth, Fernando CORRÊA. Cell-surface-targeting-domain-polymer-payload conjugate. (WO2025184423A1)
    https://patents.google.com/patent/WO2025184423A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=2